SAVA Archives - Page 2 of 2 - Blue Horseshoe Stocks

Massive Trove of Options Ideas

More Options Updates:

As we close out another stellar trading week and head into this long weekend, we’re happy to report unbroken options trading success in every session along the way. We put up ideas in the CHPT, NTNX, CHWY and SIG chains. They all produced intraday gains, but we’re going to leave out SIG because while they were respectable moves, none of the target managed to quite reach multi-bag status.

Our big runners were the CHPT Weekly $24-25 Calls, the NTNX Weekly $37.50-40 Calls, and the CHWY Weekly $83-79 Puts, and they put forth some really nice opportunities for traders to hit it big on the day.

CHPT Weekly $24-25 Calls
$24: .08-.33 (+312%)
$24.50: .09-.21 (+277%)
$25: .05-.15 (+200%)
_____

NTNX Weekly $37.50-40 Calls
$37.50: 2.00-4.25 (+112%)
$38: 1.67-3.75 (+125%)
$38.50: 1.75-3.00 (+71%)
$39: 1.47-2.73 (+86%)
$40: .63-1.97 (+213%)
_____

CHWY Weekly $83-79 Puts
$83: 2.60-4.07 (+57%)
$82: 1.90-3.22 (+69%)
$81: 1.25-2.35 (+88%)
$80: .85-1.62 (+91%)
$79: .51-1.04 (+104%)

Fresh Options Ideas*:
SPY Weekly $453-455 Calls
MDB Weekly $440-455 Calls
DOCU Weekly $297.50-305 Calls
AVGO Weekly $490-497.50 Calls
SAVA Weekly $56-59 Calls

*Beginning-to-intermediate level traders should not attempt to trade weekly contracts on a Friday. Seasoned traders should have access to disposable funds before attempting to do so.

Extended Watchlist:
APOP, FTFT, ENVB, BRTX, IPSI, CCAJ, PBYA, VGLS, DEWM, DVLP

Persistent Options Success & More

Another Clean Sweep on Options:

We’ve been rattling off some excellent options opportunities for our readers this week, and yesterday was another hallmark performance on our part. We slated three sets of fresh options contracts for observation in our premarket report yesterday morning, and each one recorded a solid intraday move for us.

We were targeting the AMC Weekly $44-46 Calls, the DKS Weekly $122-130 Calls, and the KC 09/17 $30-35 Calls, and for the second consecutive session we picked a trio of winners and were treated to solid intraday profit chances across the board.

The daily ranges and total possible gains on those targets were as follows:

AMC Weekly $44-46 Calls
$44: 3.30-7.20 (+118%)
$45: 2.99-6.60 (+121%)
$46: 2.80-6.20 (+121%)
_____

DKS Weekly $122-130 Calls
$122: 8.26-12.90 (+56%)
$125: 5.34-10.38 (+94%)
$130: 3.01-6.60 (+119%)
_____

KC 09/17 $30-35 Calls
$30: 1.25-2.20 (+76%)
$35: .39-.60 (+76%)

Fresh Options Ideas:
SAVA 09/10 $93-94 Calls
ULTA Weekly $405-415 Calls
CRM Weekly $262.50-270 Calls

Extended Watchlist:
YY, GSMG, RIDE, UUU, ZOM, BLUW, ILUS, KYNC, TOMDF, IQST, FORW. STSN, BRGO, HBRM

2nd & 3rd Thousand Percent Gainers of the Year!

Inpixon INPX

We’re circling back this morning to update the new highs that we got from INPX on Friday. We were just mentioning in the premarket that morning, we have been tracking the stock since our report on 12/02. subsequent to which time we would observe a low of .037.

Friday’s new high came in at .65, which marks an incredible increase of 1657% in just over a month since our initial alert! The move registered as the second highest daily gainer on the NASDAQ for Friday, and the second thousand percent gainer we’ve delivered for our newsletter subscribers for the New Year!

Lamb Weston Holdings, Inc. LW – Options Recap

Speaking of thousand percent gainers, we also bagged our third of 2020 with our fresh options idea from Friday morning’s report! We put the Lamb Weston Holdings, Inc. LW 01/17 $85-90 Calls on watch, and the single session gain opportunities were excellent, including a twelve-bagger!

The $85 Calls ran from 1.76-9.30 for total gains of up to 428%, while the $90 Calls exploded from a low of .35 all the way up to 4.80. That goes down as an awesome intraday run of 1271%
____

Fresh Idea:
Cal Maine Foods, Inc. CALM Weekly $39-37.50 Puts

Other Recent Gainers:

We alerted on ContraFect Corp. CFRX in our report from December 17th, and the stock has gone on to record a move from .38-.75 (+97%).

We put Cassava Sciences, Inc. SAVA on Thursday morning, and it finished the week with a two-day swing from 6.25-10.95, a gain of 75%

Extended Watchlist:
FCEL, DMPI, NDRA, AUMN, LODE, GNPX, PULM

2019 Winners That Could Keep Running in 2020

FuelCell Energy, Inc. FCEL

For our first mention of the year, we are looking at FCEL, which ended up registering as the NASDAQ’s #1 daily gainer on New Year’s Eve. We’ve been tagging this one amid its recent push to new highs, but we actually began our coverage in October. (We always have receipts! You can view all of our reports containing a mention of this stock by clicking here.) The stock established its bottom shortly thereafter on Halloween, when it registered a low of .23.

FCEL had a productive fall and early winter, and on Tuesday, pushed to a brand new high of 2.75. That’s an unbelievable increase of 1096% in exactly two months’ time. Even if you only caught our more recent December 20th alert on FCEL after which the PPS low was .71, Tuesday’s high enabled gains of up to 272%

It was a great call to close out 2019, and we’re ready to tackle 2020 head-on! We won’t rule out the possibility of FCEL continuing its incredible uptrend, in fact, the stock has set another new high of 2.95 here in the premarket so far!

Other New Highs

We recently brought up ONCY and OWCP for their solid performances after we had placed them on watch, and both finished out 2019 by recording new highs as well!

Oncolytics Biotech, Inc. ONCY was coincidentally tagged in the same November report as FCEL, as well as several more recent mentions, if you check the tag in our archives. Just a couple of days following that November alert, ONCY saw a low of .82. On Tuesday its new high came in at 6.02, for a whopping gain of 634%
____

As for OWC Pharmaceutical Research Corp. OWCP, on Tuesday morning we were just heralding the spectacular progress it has made since our initial call at .028, and the stock once again made a multibag intraday surge to new highs to close out the year, hitting .09, and registering as an increase of 221%

Fresh Options Idea:
RAD 01/10 $16.50-18 Calls

Extended Watchlist:
TLRY, CGC, CRON, GEVO, SAVA, AKCA, AKRX (Bottom bouncer)

Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.

Verastem Inc. VSTM

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.

Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE